(Research Triangle Park, N.C.) Quintiles today announced the appointment of Vincent Aurentz as Executive Vice President, Customer Solutions Business, to head a newly formed unit of dedicated customer teams that will deliver customized solutions across Quintiles’ global businesses – Clinical, Commercial, Capital and Consulting – for the world’s leading biopharmaceutical companies.
“Our goal is to make it easier for customers to do business with us by building deeper relationships that better enable us to deliver on our promise to customers for quality results across all of our global services,” Aurentz said. “We are entering an era where our customers must make transformational changes to their strategies. The Customer Solutions Business has the opportunity to play a critical role at the intersection of Quintiles and its customers.”
Aurentz brings more than 20 years of experience in the biopharma industry to his new role. Most recently, he was Executive Vice President of Portfolio Development and a member of the Executive Board, for Merck Serono in Geneva Switzerland, where he headed R&D Product teams, Portfolio Management, Business Development & Licensing, as well as Pricing & Health Economics.
“I have seen first-hand the enormous pressures that are creating a fundamental shift in our industry,” Aurentz said. “I look forward to playing a part in bringing all the services of Quintiles to solve the needs of our customers.”
Aurentz and his family recently relocated to North Carolina from Geneva, Switzerland.
Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more than 20,000 engaged professionals in 60 countries around the globe works with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies navigate risk and seize opportunities in an environment where change is constant. For more information, please visit www.quintiles.com.